Schering-Plough Receives Marketing Approval For Remeron In Japan
Published: 09-Jul-2009
Remeron 15mg tablets to treat major depressive disorder
Schering-Plough has received marketing approval for Remeron/Reflex (mirtazapine) 15mg tablets, for the treatment of major depressive disorder. The product was developed jointly with Meiji Seika Kabushiki Kaisha. Schering-Plough and Meiji Seika would market the product under the trade names, REMERON and Reflex, respectively.
Thomas Koestler, President and Executive Vice President of Schering-Plough Research Institute, said: Remeron came to us from the Organon research laboratories, and we are pleased that this new treatment option will now be available in Japan to help meet the needs of physicians and their patients suffering from depression.
This approval is the eighth new product we have brought to the Japanese market since 2007 and represents important progress in extending our presence in Japan, a critical part of our geographic expansion, he added.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
WebWise Learning
Turning Information into Working Knowledge ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Valsynthese
Hazardous Chemistry in Safe Hands ...
USB
Products from Affymetrix ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
